Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FP1RY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,323
Award facts
- Contract value 100% obligated
- $30,322.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $30,322.89 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections. This competitively awarded, non-set-aside contract was executed on January 23, 2026, with an ultimate completion date of January 26, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat conditions including moderate-to-severe eczema, asthma, and other allergic inflammatory conditions, making this delivery order part of the Defense Logistics Agency's pharmaceutical supply operations for military healthcare systems.
This delivery order operates under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The IDC serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The current delivery order represents a routine task order execution under this established contract vehicle, leveraging AmerisourceBergen's extensive capability as a major pharmaceutical distributor serving federal medical procurement needs across the military health system and other government healthcare agencies.
Quick answers
Who was awarded contract SPE2DR26FP1RY?
SPE2DR26FP1RY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FP1RY worth?
The government has obligated $30,323 on SPE2DR26FP1RY.
Is contract SPE2DR26FP1RY an order under another contract?
Yes. SPE2DR26FP1RY is a delivery order under SPE2DR25D3014, an indefinite delivery contract.
Was contract SPE2DR26FP1RY competed?
The extent of competition for SPE2DR26FP1RY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award